NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Galiano Gold Inc. ("Galiano" or the "Company") (NYSE: GAU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rezolve AI PLC ("Rezolve" or the "Company") (NASDAQ: RZLV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ: MLTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lesaka Technologies, Inc. ("Lesaka" or the "Company") (NASDAQ: LSAK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Informatica Inc. ("Informatica" or the "Company") (NYSE: INFA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MediaAlpha, Inc. ("MediaAlpha" or the "Company") (NYSE: MAX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Palantir Technologies Inc. ("Palantir" or the "Company") (NASDAQ: PLTR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Firefly Aerospace Inc. ("Firefly" or the "Company") (NASDAQ: FLY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Innovative Solutions and Support, Inc. ("IS&S" or the "Company") (NASDAQ: ISSC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cybin Inc. ("Cybin" or the "Company") (NYSE: CYBN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Alcoa Corporation is rated Buy with a $38.52/share price target, reflecting moderate aluminum pricing and improved supply chain economics. AA is navigating tariff challenges by redirecting Canadian production and leveraging Brazilian refineries, with potential upside if Midwest aluminum prices improve. Operational updates include the San Ciprian facility restart, Kwinana Refinery closure, and a potential gallium project in Western Australia.

RBC Bearings (RBC) possesses solid growth attributes, which could help it handily outperform the market.

Sonic Automotive (SAH) could produce exceptional returns because of its solid growth attributes.

FirstService (FSV) is well positioned to outperform the market, as it exhibits above-average growth in financials.

The company's industry-leading position, persistent strength, outperformance, cash flow, and value-building capability have its stock price on track to reach new all-time highs, potentially before the year's end.

Texas Instruments (NASDAQ:TXN) faces mounting pressure as macroeconomic headwinds collide with a rich valuation, signaling tighter near-term growth prospects for the semiconductor giant.

CAVA is a compelling rebound play, down over 40% this year but outperforming peers amid industry-wide comp sales declines. I raise CAVA to a "Strong Buy," citing its innovative, gamified loyalty program and upcoming Q3 earnings as catalysts for renewed growth. CAVA's new tiered rewards system, with status matching and higher points rates, sets it apart from competitors and encourages increased diner frequency.

Access Denied Access Denied You don't have permission to access "http://www.cnbc.com/2025/10/13/oracle-ceo-magouyrk-of-course-openai-can-pay-60-billion-per-year.html" on this server. Reference #18.c724c317.1760377802.12ed0c10 https://errors.edgesuite.net/18.c724c317.1760377802.12ed0c10

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.